Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,315 signal articles · 49 in last 24h · 115,654 total before filter · latest 2h ago
49last 24h
1756last 7d
299● bullish (7d)
168● bearish (7d)
205publishers
AllMacro311Earnings818M&A101Regulatory25Product17Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
US Stock Market Today S&P 500 Futures Rise On Earnings And Inflation Crosscurrents
Simply Wall St.25d agoneutral
US Stock Market Today S&P 500 Futures Rise On Earnings And Inflation Crosscurrents

The Morning Bull - US Market Morning Update Wednesday, Jul, 22 2026 US stock futures are pointing higher, with key contracts linked to the S&P 500 up about 0.5% and Nasdaq 100 futures up roughly 1.3%, as investors weigh fresh inflation worries against easing rate fears abroad. In the US, the 10 year Treasury yield sits near 4.6%, and markets see roughly a 50 to 60% chance of a Federal Reserve rate hike in September, which matters for mortgage costs, credit cards and growth focused stocks. At...

What Oklo (OKLO)'s Role in Federally Backed AI Data Center Nuclear Project Means For Shareholders
Simply Wall St.25d agobullish
What Oklo (OKLO)'s Role in Federally Backed AI Data Center Nuclear Project Means For Shareholders

Earlier this week, the Trump administration selected Oklo and X-energy to participate in a US$200 million federal initiative to fast-track advanced nuclear reactors for powering AI data centers, alongside technology partners such as Microsoft and Nvidia, with support routed through the Department of Energy and national laboratories. This move places Oklo at the center of a federally backed effort to link next-generation nuclear power with AI infrastructure, potentially influencing how...

Is Washington Building a Tariff Wall Around American AI?
Insider Monkey25d agoneutral
Is Washington Building a Tariff Wall Around American AI?

Moonshot AI’s July 17 release of Kimi K3 has confronted Washington with an awkward fact: a Chinese open-weight model can approach leading American systems in coding and agentic tasks while charging less, though we challenge the simplicity of that premise here. On July 20, the White House was considering options to block or sharply restrict […]

Anthony Scaramucci Explains Why He's Long Bitcoin and Gold: 'Imagine an American President...Sitting in Front of a $55 Trillion Deficit'
Benzinga25d agoneutral
Anthony Scaramucci Explains Why He's Long Bitcoin and Gold: 'Imagine an American President...Sitting in Front of a $55 Trillion Deficit'

SkyBridge Capital founder Anthony Scaramucci positioned Bitcoin (CRYPTO: BTC) and gold as “part of the answer” to a changing monetary system under strain from fiscal pressures and declining purchasing power. Deficit Spending to Trigger High Inflation? Scaramucci voiced his concerns on X about the potential impact of deficit spending and inflation on the economy. The former White House Communications Director warned that national debt could rise from the current $39 trillion to $55 trillion withi

Asian shares edge higher after Wall Street climb, even as Brent oil keeps rising
Associated Press25d agoneutral
Asian shares edge higher after Wall Street climb, even as Brent oil keeps rising

Asian shares were mostly higher Wednesday following a rally on Wall Street, despite concerns about higher oil prices and inflation. Japan's benchmark Nikkei 225 rose 1.9% to 67,511.12, after the government reported that both imports and exports rose last month from a year earlier, as the weakening yen raised the value of both when converted from dollars to yen. More gains for makers of computer chips and other companies benefiting from the artificial-intelligence boom carried Wall Street higher.

Bloomberg26d agoneutral
High-Risk Bets That Burned Korean Traders Are Making a Comeback

(Bloomberg) -- South Korea’s risk-loving retail investors are flocking to a leveraged instrument that has inflicted severe losses in the past, adding to concerns about abrupt unwinding of wagers as the stock market gyrates.Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesTrump Sets 100% Tariff on Generic Drugs With Two-Year DelayTrump Extends Pardons to Companies, Echoing a 17th Century KingSpaceX Set to Unlock $116 Billion in Shares After IPO Res

Wall Street ends higher on chip stocks recovery; earnings draw focus
Reuters Videos26d agoneutralVIDEO
Wall Street ends higher on chip stocks recovery; earnings draw focus

<body><p>STORY: U.S. stocks closed higher on Tuesday, with the Dow gaining roughly three-quarters of a percent, the S&P 500 adding nearly nine-tenths of a percent and the Nasdaq climbing about 1.3%.</p><p>Gains in recently battered semiconductor stocks pushed the Philadelphia Semiconductor Index more than 5% higher. It was the index's second consecutive advance after ending Friday more than 20% below its record high, reached in late June.</p><p>Meanwhile, investors looked past a 2% rise in oil prices as well as a fresh tariff battle, after President Donald Trump slapped a 50% duty on a wide range of imports from Canada.</p><p>Eric Parnell is chief market strategist at Great Valley Advisor Group.</p><p>"It's another day in the market and it's another tariff headline coming out of Washington, DC... But we've been down this road many, many times with tariffs over the last 12 to 18 months. And on a micro level, we can dissect what's the implication going to be for the beverage industry or the food industry associated with some of these tariffs. But what we've really seen, and we've also seen it with the Iran conflict, once the market gets comfortable with its reaction function, then it largely dismisses these headlines. And I think we should continue to expect this going forward."</p><p>Stocks on the move Tuesday included Super Micro Computer, which closed 7% higher and climbed another 16% in extended trading after the AI server maker said it expects gross margins for the quarter to be above its previous forecast.</p><p>Shares of 3M gained more than 7% after the industrial giant lifted its full-year profit forecast.</p><p>And shares of Hasbro jumped nearly 9% after the company raised its annual revenue and profit forecasts, betting on demand for its digital gaming and "Magic: The Gathering" products.</p><p>The focus this week now turns to results from tech giants Alphabet, Tesla and Intel.</p></body>

Bloomberg26d agoneutral
JPMorgan, Goldman Set for $100 Million Paydays on SoftBank’s Record Loan

(Bloomberg) -- Global banks are poised to reap a windfall from SoftBank Group Corp.’s unprecedented borrowing binge as they fund the debt-laden conglomerate’s enormous artificial intelligence bet.Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot’s Gamble on Big Models Pays OffYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawUS Allies in Persian Gul

Bloomberg26d agobullish
Super Micro Jumps After Preliminary Outlook Shows Rising Backlog

(Bloomberg) -- Super Micro Computer Inc. shares rose more than 15% in extended trading after the server maker issued preliminary quarterly results saying its order backlog rose to a record in excess of $60 billion.Most Read from BloombergApple to Launch 'Upgrade' Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot's Gamble on Big Models Pays OffYemen's Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawUS All

Bloomberg26d agobullish
Super Micro Jumps After Preliminary Outlook Shows Rising Backlog

(Bloomberg) -- Super Micro Computer Inc. shares rose more than 15% in extended trading after the server maker issued preliminary quarterly results saying its order backlog rose to a record in excess of $60 billion.Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot’s Gamble on Big Models Pays OffYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawUS All

Treasury Yields Higher Ahead of Fed Meeting
Barrons.com26d agoneutral
Treasury Yields Higher Ahead of Fed Meeting

Treasury's fell sending yields higher, concluding a day of light U.S. economic data ahead of the Federal Reserve's interest rate meeting next week. Brent crude futures added 2% to settle above $90 a barrel.

Bloomberg26d agoneutral
OpenAI Names BNY, Nubank CEOs to Board Ahead of IPO

(Bloomberg) -- OpenAI has appointed two financial services executives to its board of directors, drawing on their experience as the company moves toward a Wall Street debut. Most Read from BloombergApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesChina AI Sensation Moonshot’s Gamble on Big Models Pays OffYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Th

AI Spending, Inflation, and 3 More Reasons Why Tech Is Hurting
Barrons.com26d agoneutral
AI Spending, Inflation, and 3 More Reasons Why Tech Is Hurting

Tech has been dropping for over a month under the weight of a host of worries. No, this agonizingly slow, tortured drawdown is because of five issues—none that haven’t been talked about plenty but laid out well by Sevens Report’s Tom Essaye. Tech has done a 180 and become a capital intensive sector, spending hundreds of billions this year alone.

Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Reuters Videos26d agoneutralVIDEO
Novo sues Lilly, claiming misleading ads in weight-loss drug battle

<body><p>STORY: :: Novo Nordisk claims misleading ads in Eli Lilly weight-loss drug lawsuit</p><p>:: July 21, 2026</p><p>:: Maggie Fick, European Pharma Industry Correspondent</p><p>"Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising and claiming its weight-loss medicines outperform Novo's drugs." //</p><p>"Novo is alleging in its suit that Lilly's advertisements compare weight-loss results of about 50 pounds for its drug Zepbound with about 33 pounds for Wegovy, even though no head-to-head clinical trial has compared the highest approved doses of the medicines."</p><p>"Pharmaceutical companies regularly sue each other over claims related to patent infringement, for example, but false advertising suits, such as the one filed today, are less common."</p><p>"Novo Nordisk was first to market with its weight-loss injection Wegovy several years ago, but it later lost the lead to Eli Lilly, after that company launched a rival injection called Zepbound in the United States. Last year, Novo replaced its CEO and was forced to issue multiple profit warnings as it fell further behind Eli Lilly in this really competitive and booming obesity drug market, which analysts expect to be worth more than $100 billion by 2030. This year, Novo has actually sort of landed a counterpunch with its oral Wegovy pill. It was able to launch that drug ahead of Eli Lilly. Lilly has, in April, launched its own pill, a weight-loss pill. But Novo has managed to keep up strong sales even since the launch of Lilly's pill."</p><p>"Both companies report quarterly results in the next couple of weeks."</p><p>:: Novo Nordisk</p><p>:: Eli Lilly</p><p>The Danish company filed the lawsuit in U.S. District Court ‌in New Jersey, alleging Lilly violated federal and state false advertising and unfair competition laws, including the Lanham Act, through nationwide advertising campaigns for obesity drug Zepbound and diabetes treatment Mounjaro.</p><p>Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo's Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight loss.</p><p>But Indianapolis-based Eli Lilly said it stands firmly behind its ads, which are based on the results of its SURMOUNT-5 trial. That ⁠trial — completed in 2024 — compared patients on 10 mg or 15 mg of Lilly's Zepbound to patients on 1.7 mg or 2.4 mg doses of Wegovy. The FDA approved ​a 7.2 mg dose of Wegovy in March of this year.</p></body>

GM Boosts 2026 Outlook on Premium Pricing for Big Trucks
Bloomberg26d agoneutralVIDEO
GM Boosts 2026 Outlook on Premium Pricing for Big Trucks

General Motors&nbsp;raised its full-year profit forecast by another $500 million after beating second-quarter earnings estimates, powered by stronger margins on its largest vehicles and lower tariff costs.&nbsp;Bloomberg's David Welch joins to discuss.

Bloomberg26d agoneutral
Trump Extends Pardons to Companies, Echoing a 17th Century King

(Bloomberg) -- Ryan LaLone received a pardon this month for a conviction tied to tampering with diesel emissions systems. Just as importantly, so did his company. Most Read from BloombergYemen’s Houthis to Impose Maritime Blockade on Saudi ArabiaChina AI Sensation Moonshot’s Gamble on Big Models Pays OffTrump Vows 50% Tariff on Canadian Goods Using Depression-Era LawMoonshot’s Kimi K3 May Be More About Memory Than ComputeIran Says Mediators Stepping In After Days of US ClashesThe twin reprieves

Amazon's $595 titanium luxury watch is a Seiko on the inside
TheStreet26d agoneutral
Amazon's $595 titanium luxury watch is a Seiko on the inside

Luxury watches seem to remain popular, even during times of financial crisis and tumult. That's probably because watches are often purchased as the representation of a personal or professional milestone. Those moments don't simply stop happening because the job market is slow or because inflation ...